Effectiveness and Safety of Ezetimibe Added to Statin Therapy in Patients with Primary Dyslipidaemia not Achieving the LDL-C Treatment Goal on Statin Monotherapy

By González Carlos A.   Rubio-Guerra Alberto F.   Pavía Abel   Redding Francisco J.   Cervantes José L.   Zacarías José L.   Yza Rubén   Carranza Jaime   Fernández Pedro   Morales Enrique   Robles Francisco J.   Leyva José L.   Rodríguez Leticia  

Clinical Drug Investigation, Vol. 27, Iss. 5, 2007-01 ,pp. : 333-337

Adis International

Access to resources Recommend Favorite

Ezetimibe add-on to atorvastatin: evidence for adoption in Canada

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Ezetimibe enhances efficacy of atorvastatin in high risk patients

By  

Inpharma, Vol. 1, Iss. 1463, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Atorvastatin in Patients with Type 2 Diabetes Mellitus: A Pharmacoeconomic Analysis of the Collaborative Atorvastatin Diabetes Study in the Belgian Population

By Annemans L.   Marbaix S.  

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 133-142

Adis International

Access to resources Recommend Favorite

The Cost of Reaching National Cholesterol Education Program (NCEP) Goals in Hypercholesterolaemic Patients: A Comparison of Atorvastatin, Simvastatin, Lovastatin and Fluvastatin

By McLain R.W.  

PharmacoEconomics, Vol. 14, Iss. 1, 1998-07 ,pp. : 59-70

Adis International

Access to resources Recommend Favorite